Role of Probiotics in COVID-19 Management?

Role of Probiotics in COVID-19 Management?

Samar Osama Ahmed Hassan (1), Manal Sabry Mohamed (2), Mina Mikhail Nessim (2), Mohamed Nabil Badawy Al Ashram (2), Mohamed Farouk Allam (1,3)

 

1. Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

2. Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

3. Department of Preventive Medicine and Public Health, University of Cordoba School of Medicine, Cordoba 14004, Spain.

 

*Correspondence: Mohamed Farouk Allam (farouk.allam@med.asu.edu.eg)

World Journal of Medical Microbiology, 2022, 1, 372.

DOI: 10.31586/wjmm.2022.372

 

Abstract

Probiotics as an intestinal microbe regulator, not only improve the ability of the gastrointestinal microbiota to modulate immune activity, but also strengthen the body's immune system, inhibit allergic reactions and has a significant role especially in the anti-viral immunomodulation. Therefore, in patients with COVID-19, the intestinal micro-eco-regulator, represented by probiotics, may be a therapeutic choice. However, there is still a lack of evidence[1]based studies to support probiotic treatment of patients with COVID-19. New cohort studies and randomized controlled clinical trials to assess the effectiveness of probiotics in the management of COVID-19 are strongly and urgently needed.

 

Keywords: Probiotics, COVID-19, Gut microbiota, clinical trials, cohort study, GIT.

World Journal of Medical Microbiology, 2022, 1, 372.

 

https://www.scipublications.com/journal/index.php/wjmm/article/view/372